This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ProQuad

Merck & Co., Inc.

Drug Names(s): roquad Measles, Mumps, Rubella and Varicella Virus Vaccine

Description: PROQUAD combines two established Merck vaccines, M-M-R II (Measles, Mumps, Rubella Virus Vaccine Live) and VARIVAX [Varicella (Oka/Merck) Virus Vaccine Live]. ProQuad is approved in the US for active immunization for the prevention of measles, mumps, rubella, and varicella in individuals age 12 months to 12 years.

Deal Structure: Historical sales for ProQuad during 2009 are not available because Merck faced supply constraints.


ProQuad News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug